Skip to content

To Rule Out The Efficacy Of Chandanadi Lepa And Dushivishari Agad Due To Kritrim Visha Acne Cosmetica

Role Of Chandanadi Lepa And Dushivishari Agad In Kritrim Visha Janya Padminikantaka (Acne Cosmetica) - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059525
Enrollment
40
Registered
2023-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

Pandit Khushilal Sharma Govt Auto Ayurveda College And Institute Bhopal MP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age group 20 to 50 years of either sex will be selected irrespective of cast, creed, religion, occupation, habits etc. 2.Patients who has been diagnosed with Kritrim visha janya padminikantaka(Acne Cosmetica). 3.Patients provides informed consent prior to study procedure and is willing to join the study.

Exclusion criteria

Exclusion criteria: 1.Patients below the age of 20years and above 50 years. 2.Patients those who have hormonal imbalance and irregular menstrual cycle . 3.Patients suffering from any other severe systemic illness. 4.Pregnant and lactating mothers should be excluded. 5.PCOD, PCOS. 6.Patient who is not willing to join the clinical study.

Design outcomes

Primary

MeasureTime frame
It Is Expected That This Study Would Be Able To Reveal The Potency Of Chandanadi Lepa And Dushivishari Agada In The Management Of Kritrim Visha Janya Padminikantaka (Acne Cosmetica)Timepoint: 3O Days After Starting Of Intervention

Secondary

MeasureTime frame
To Enhance The Beauty.Timepoint: 30 DAYS

Countries

India

Contacts

Public ContactDr Mitali Verma

Pandit Khushilal Sharma Govt (Auto) Ayurveda College And Institute Bhopal 462003

urmila.shukla.393950@gmail.com9425672655

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026